For a peptide like semaglutide, this requires a crossover pharmacokinetic study in 40-60 healthy volunteers
& Ahmad, N
Still, for people who prefer pills, the Wegovy tablet lands in a sweet spot between convenience and effectiveness
Orforglipron is a non-peptide oral GLP-1 that could change accessibility entirely
Semaglutide for weight loss Semaglutide is the active ingredient in the brand-name drugs Ozempic, Wegovy, and Rybelsus and in compounded semaglutide
In the diabetes TRIUMPH-2 trial, reported side effects included: Diarrhea (around 27 to 34 percent of participants, depending on the dose) Nausea (14 to 28 percent) Constipation (14 to 17 percent) Decreased appetite (6 to 17 percent) Vomiting (6 to 16 percent) In the TRIUMPH-3 trial for adults with severe obesity and heart disease, participants reported: Diarrhea (around 24 to 30 percent of participants, depending on the dose) Nausea (22 percent) Constipation (16 to 18 percent) Decreased appetite (14 to 15 percent) Hyperglycemia, or high blood sugar (3 to 4 percent) The high rates of diarrhea surprised Ali
